rss
J Neurol Neurosurg Psychiatry 2000;68:689-690 doi:10.1136/jnnp.68.6.689
  • Editorial commentary

Botulinum toxin in muscle spasticity

  1. R J HARDIE
  1. Wolfson Neurorehabilitation Centre, Atkinson Morley's Hospital, Copse Hill, Wimbledon, London, SW20 0NE, UK.rhardie@sghms.ac.uk

      Botulinum toxin type A has been widely used in focal dystonias for more than 10 years, but it is also undoubtedly of benefit in the relief of spasticity,1 a far commoner cause of motor impairment and neurological disability. The injection technique, by contrast with more traditional peripheral nerve blocks, requires little special equipment and can be learnt relatively easily. Thus it seems likely that botulinum toxin is destined to become much more widely used for this indication, although good evidence on which to base management decisions for busy clinicians is lacking.

      There is uncertainty about the best delivery …

      Register for free content

      The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

      BMJ Careers - Latest neurology and neurosurgery jobs